Cancer Research Folkman
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boon, K.
Right arrow Articles by Riggins, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boon, K.
Right arrow Articles by Riggins, G. J.
[Cancer Research 65, 703-707, February 1, 2005]
© 2005 American Association for Cancer Research


Priority Reports

Genomic Amplification of Orthodenticle Homologue 2 in Medulloblastomas

Kathy Boon1, Charles G. Eberhart2 and Gregory J. Riggins1

Departments of 1 Neurosurgery and 2 Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Request for reprints: Gregory J. Riggins, Department of Neurosurgery, 5th Floor, Mason F. Lord Building, Center Tower, 5200 Eastern Avenue, Baltimore, MD 21224. Phone: 410-550-9686; Fax: 410-550-9689; E-mail: griggin1{at}jhmi.edu.

To better understand the genetic basis of medulloblastoma development, we sought genomic amplifications and deletions in these tumors using digital karyotyping in combination with expression analysis. Five medulloblastoma genomes were karyotyped by sequencing an average of 195,745 genomic DNA tags for each analysis. Tags were tallied at unique positions and mapped to the human genome to determine DNA copy numbers in high resolution along each chromosome. Genomic alterations normally associated with medulloblastomas, including MYC amplification and isochromosome 17q, were easily detected. Surprisingly, analysis of only five genomes revealed novel amplicons on chromosome 14q, one of which contained the orthodenticle homologue 2 (OTX2) homeobox gene. DNA copy number analysis showed that OTX2 had undergone genomic amplification in 2 of 11 medulloblastoma cell lines and 8 of 42 primary tumors. The three genes and a predicted open reading frame flanking OTX2 in the 14q amplicon were not amplified in at least one of the other nine amplicons, implicating OTX2 as the gene target conferring a selective advantage. The degree of OTX2 amplification ranged from 8 copies to over 50 copies of the gene. OTX2 transcript was highly and specifically expressed in medulloblastoma or developing cells. Serial analysis of gene expression of 240 different human tumors or normal tissues revealed that 96% of all 783 OTX2 transcripts sequenced were in medulloblastomas or embryonic stem cells. OTX2 functions to specify the fate of neuroectoderm in various regions of the developing brain. This developmental role is consistent with the evidence suggesting that OTX2 is a medulloblastoma oncogene.

Key Words: Medulloblastoma • Genomic Amplification • Homeobox Gene • Digital Karyotyping




This article has been cited by other articles:


Home page
JCOHome page
X. Fan and C. G. Eberhart
Medulloblastoma Stem Cells
J. Clin. Oncol., June 10, 2008; 26(17): 2821 - 2827.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
I-M. Siu, R. Bai, G. L. Gallia, J. B. Edwards, B. M. Tyler, C. G. Eberhart, and G. J. Riggins
Coexpression of neuronatin splice forms promotes medulloblastoma growth
Neuro-oncol, January 1, 2008; 10(5): 716 - 724.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
J. M. de Bont, R. J. Packer, E. M. Michiels, M. L. d. Boer, and R. Pieters
Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective
Neuro-oncol, January 1, 2008; 10(6): 1040 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. T. Park, M. Li, K. Nakayama, T.-L. Mao, B. Davidson, Z. Zhang, R. J. Kurman, C. G. Eberhart, I.-M. Shih, and T.-L. Wang
Notch3 gene amplification in ovarian cancer.
Cancer Res., June 15, 2006; 66(12): 6312 - 6318.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Puelles, D. Acampora, R. Gogoi, F. Tuorto, A. Papalia, F. Guillemot, S.-L. Ang, and A. Simeone
Otx2 controls identity and fate of glutamatergic progenitors of the thalamus by repressing GABAergic differentiation.
J. Neurosci., May 31, 2006; 26(22): 5955 - 5964.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I.-M. Shih, J. J.-C. Sheu, A. Santillan, K. Nakayama, M. J. Yen, R. E. Bristow, R. Vang, G. Parmigiani, R. J. Kurman, C. G. Trope, et al.
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma
PNAS, September 27, 2005; 102(39): 14004 - 14009.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.